Manulife (Manufacturers Life Insurance)’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,798
Closed -$34K 2985
2025
Q1
$34K Buy
38,798
+840
+2% +$1.17K ﹤0.01% 2864
2024
Q4
$64.1K Sell
37,958
-23
-0.1% -$41 ﹤0.01% 2904
2024
Q3
$72.9K Buy
37,981
+13,415
+55% +$30.5K ﹤0.01% 2937
2024
Q2
$60.4K Buy
+24,566
New +$65.9K ﹤0.01% 2936
2023
Q4
Sell
-19,564
Closed -$89.6K 3010
2023
Q3
$89.6K Sell
19,564
-4,247
-18% -$40.6K ﹤0.01% 2840
2023
Q2
$266K Buy
+23,811
New +$253K ﹤0.01% 2438
2022
Q2
Sell
-425,216
Closed -$4.2M 3108
2022
Q1
$4.2M Buy
425,216
+10
+0% +$99 ﹤0.01% 1274
2021
Q4
$4.21K Buy
425,206
+34
+0% +$336 ﹤0.01% 1315
2021
Q3
$4.17M Buy
425,172
+172
+0% +$1.69K ﹤0.01% 1313
2021
Q2
$4.3M Buy
+425,000
New +$4.3M ﹤0.01% 1347

Other funds holding PROK

Manulife (Manufacturers Life Insurance)'s PROK Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of ProKidney (PROK) in Q2 2025, closing a stake of 38,798 shares — an estimated $34K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PROK in Q2 2021 and held it in 10 quarters. The position peaked at $4.3M in Q2 2021. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 38,798 ProKidney shares in Q2 2025, an estimated $34K.
  • Manulife (Manufacturers Life Insurance) first reported a position in ProKidney in Q2 2021 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s ProKidney position peaked at $4.3M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.